Big Data Marketing Medicine Pharma Companies 
Drug Discovery World
JULY 18, 2022
Big data and AI are all the rage. But, beyond these buzzwords and the quantity of data, what’s next for these powerful tools? Troy Groetken says that data has the ability to create personalised, predictive and preventative medicine tailored to individual patients and identified patient groups/populations.
Drug Discovery World
FEBRUARY 6, 2024
Companies leading the way There are a number of companies leading the charge in applying innovative technologies, particularly artificial intelligence (AI) and machine learning (ML), to the search for new medicines. Digital tech is also helping researchers to find target candidates for some of the most challenging disease areas.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
pharmaphorum
JULY 14, 2022
A pilot study has been launched by the EMA to see whether it is helpful for regulators to look at the ‘raw data’ from clinical trials submitted in support of new marketing application along with the usual structured analyses from sponsors.
pharmaphorum
FEBRUARY 1, 2022
Across the industry, pharma companies are turning to AI and real-world data to address many of the challenges of running clinical trials. Can the combined potential of new AI technologies and real-world patient data hold the key to overcoming the challenges in clinical trial design that have historically led to trial failure?
pharmaphorum
SEPTEMBER 18, 2020
But although it was dubbed a “dangerous game”, some companies came out on top… On 6th April 1999, two companies with similar science-based cultures and a shared vision of the pharmaceutical industry came together to form what’s now considered as one of the top ten pharma companies in the world: AstraZeneca.
Drug Discovery World
AUGUST 22, 2023
Claire D’Abreau-Hayling, Chief Scientific Officer at Sandoz, examines how generic products can relieve industry pressure and improve access to essential medicines. Off-patent medicines today account for about 80% of global prescriptions at an estimated 20% of the total cost.
Pharma Marketing Network
JUNE 11, 2020
RJ Lewis (EHS): Hello, this is RJ Lewis and we’re back for Episode 2 with John Mack and Don Langsdorf, and we’re talking about the rebirth of Pharma Marketing and Pharma Guy. So, you continue with Pharma Marketing news. So they all do things that they do very well and they cover the market very well.
Expert insights. Personalized for you.
52 
Let's personalize your content